NL
NL · NL · NL-c73714552ef8
CAMCEVI 21 mg suspensie voor injectie met verlengde afgifte
ATC L02AE02
Last synced from CBG-MEB (Netherlands) on
Identification
ManufacturerAccord Healthcare S.L.U.
CountryNL (NL)
ATC codeL02AE02
Dispensing—
ReimbursedNo
SourceCBG-MEB (Netherlands)
Last synced6/9/2026
Packs · 1
- cbg_meb_idEU/1/22/1647
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Suspensie voor injectie met verlengde afgifte",
"route": "Subcutaan gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/camcevi-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Leuprorelin",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp134996",
"excipients": [
"MELKZUUR(D,L)-GLYCOLZUUR COPOLYMEER",
"N-METHYLPYRROLIDON"
],
"substances": [
"LEUPRORELINEMESILAAT"
],
"leaflet_url": null,
"authorised_at": "2022/05/24",
"procedure_number": "EMEA/H/C/005034",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/22/1647",
"additional_monitoring": "N"
}Related drugs
Other records sharing ATC code L02AE02.
Access this data programmatically
Query CAMCEVI 21 mg suspensie voor injectie met verlengde afgifte and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.